ELBA

During a tissue biopsy, a sample of cells is removed from the body to determine the presence, cause or extent of cancer. Liquid biopsies are blood tests offering a minimally invasive, safe and sensitive alternative or complementary approach to tissue biopsies. However, the development and commercialisation of liquid biopsy approaches are currently hampered by various obstacles.

ELBA will educate 15 Early Stage Researchers with the skills to face these obstacles in key disciplines of molecular biology and medicine, bioinformatics, biostatics, mathematics, computer science, social sciences, health economics and technology assessment. ELBA will make scientific advances towards widespread implementation of blood-based diagnostics tests, create a sustainable network to foster long-term multidisciplinary relationships to accelerate clinical translation of blood-based diagnostics tests and publish a roadmap towards liquid biopsy test development.

ECPC provides the Early Stage Researchers with training courses and workshops on communicating complex research results to a public audience, understanding the patient perspective, and scientific writing. ECPC uses its communication channels to share information about the project, its results and its participants. ECPC is also represented on the Project Advisory Board to monitor project progress and provide input on the design and direction.